I want this to be perfectly clear. By replacing this definition, clause 2 removes all the other definitions that are currently in the legislation. Proposed amendment LIB-4 refers to a certain number of definitions—for example, of the WTO, the TRIPs Agreement or that sort of thing, which would not longer appear in the list of definitions.
What I'm seeking to do, obviously, is to find a way to amend the definition of “pharmaceutical product” in order to ensure, as Mr. Garneau has said, that it is consistent with the schedules, motions and clauses passed previously, while at the same time maintaining those definitions that we will need in order to interpret proposed Liberal amendment LIB-4, for example.